K. Kelly

A New Model for Stratification of Treatment Intensity in Relapsed Pediatric Hodgkin Lymphoma

K. Kelly, D. Hodgson, P. Cole, 2014, Klinische Pädiatrie.

Phase 2, open-label study of pembrolizumab in children and young adults with newly diagnosed classical hodgkin lymphoma (cHL) with slow early response (SER) to frontline chemotherapy: KEYNOTE-667

C. Mauz-Koerholz, R. Ramchandren, A. Nahar, 2019, Klinische Pädiatrie.